Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Non-GAAP research and development (R&D) expenses by Year
Non-GAAP research and development (R&D) expenses ($M) ($M)
Vertex Pharmaceuticals Non-GAAP research and development (R&D) expenses: $3,492M in FY2025, up 15.2% from a year earlier. That is the highest of the 10 years on record here.
Where the FY2025 figure comes from
“|| Non-GAAP research and development expenses | $ | 873.3 | $ | 899.8 | $ | 3,491.5 | $ | 3,030.7”
Source: Form 8-K (ex-991_q42025.htm, filed 2026-02-12) ↗
Reported in Form 8-K EX-99.1 Earnings Releases (GAAP to Non-GAAP Reconciliations).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Non-GAAP research and development (R&D) expenses ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3,492 | +15.2% | Form 8-K (ex-991_q42025.htm, filed 2026-02-12) ↗ |
| FY2024 | Dec 31, 2024 | 3,031 | +8.4% | Form 8-K (ex-991_q42025.htm, filed 2026-02-12) ↗ |
| FY2023 | Dec 31, 2023 | 2,797 | +26.9% | Form 8-K (ex-991_q42024.htm, filed 2025-02-10) ↗ |
| FY2022 | Dec 31, 2022 | 2,205 | +32.9% | Form 8-K (ex-991_q42023.htm, filed 2024-02-05) ↗ |
| FY2021 | Dec 31, 2021 | 1,658 | +20.9% | Form 8-K (ex-991_q42022.htm, filed 2023-02-07) ↗ |
| FY2020 | Dec 31, 2020 | 1,372 | +17.2% | Form 8-K (ex-991_q42021.htm, filed 2022-01-26) ↗ |
| FY2019 | Dec 31, 2019 | 1,171 | +7.5% | Form 8-K (ex-991_q42020.htm, filed 2021-02-01) ↗ |
| FY2018 | Dec 31, 2018 | 1,089 | +13.5% | Form 8-K (ex-991q42019.htm, filed 2020-01-30) ↗ |
| FY2017 | Dec 31, 2017 | 960 | +11.9% | Form 8-K (ex-991_q42018.htm, filed 2019-02-05) ↗ |
| FY2016 | Dec 31, 2016 | 858 | – | Form 8-K (ex-991_q42017.htm, filed 2018-01-31) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Non-GAAP research and development (R&D) expenses ($M), annual FY2016–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/nongaap-rd
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.